| 1 |
代永亮, 张宇哲, 张元刚, 等. 人工智能CT定量分析技术在评价不同时期肺挫伤支气管变化过程中的应用价值[J]. 中国中西医结合影像学杂志, 2024, 22(2): 184-187, 197.
|
| 2 |
王鼎, 蔡建辉. 外伤所致肺挫伤诊断与治疗的研究进展 [J/OL]. 吉林医药学院学报, 2023, 44(6): 443-446, 450.
|
| 3 |
Lee NH, Kim SH, Seo SH, et al. Prediction of respiratory complications by quantifying lung contusion volume using chest computed tomography in patients with chest trauma [J/OL]. Scientific Reports, 2023, 13(1): 6387.
|
| 4 |
Choudhary S, Pasrija D, Mendez MD. Pulmonary contusion[M]//StatPearls. Treasure Island (FL): StatPearls Publishing, 2024.
|
| 5 |
Castrillón AI, Sua LF, Sanchez A, et al. Pulmonary contusion-an unusual clinical and radiological presentation: case report [J/OL].J Investig Med High Impact Case Rep, 2024, 12: 23247096241266089.
|
| 6 |
Katzen J, Beers MF. Contributions of alveolar epithelial cell quality control to pulmonary fibrosis [J/OL]. J Clin Invest, 130(10): 5088-5099.
|
| 7 |
Coste F, Vraka A, Guerreiro I, et al. Hypoxemia: from pathophysiology to diagnosis [J/OL]. Rev Med Suisse, 2022, 18(804): 2157-2161.
|
| 8 |
Zingg SW, Gomaa D, Blakeman TC, et al. Oxygenation and respiratory system compliance associated with pulmonary contusion [J/OL]. Respiratory Care, 2022, 67(9): 1100-1108.
|
| 9 |
Westman J, Grinstein S, Marques PE. Phagocytosis of necrotic debris at sites of injury and inflammation [J/OL]. Front Immunol, 2020, 10: 3030.
|
| 10 |
Pacha O, Sallman MA, Evans SE. COVID-19: a case for inhibiting IL-17? [J/OL]. Nat Rev Immunol, 2020, 20(6): 345-346.
|
| 11 |
Zhou M, Meng L, He Q, et al. Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways [J/OL]. Front Pharmacol, 2024, 15: 1321095.
|
| 12 |
Krylova SV, Feng D. The machinery of exosomes: biogenesis, release, and uptake [J/OL]. Int J Mol Sci, 2023, 24(2): 1337.
|
| 13 |
Singh S, Paul D, Nath V, et al. Exosomes: current knowledge and future perspectives [J/OL]. Tissue Barriers, 12(2): 2232248.
|
| 14 |
Jiao Y, Zhang T, Zhang C, et al. Exosomal miR-30d-5p of neutrophils induces M1 macrophage polarization and primes macrophage pyroptosis in sepsis-related acute lung injury [J/OL]. Crit Care, 2021, 25(1): 356.
|
| 15 |
Zou S, Jie H, Han X, et al. The role of neutrophil extracellular traps in sepsis and sepsis-related acute lung injury [J/OL]. Int Immunopharmacol, 2023, 124(Pt A): 110436.
|
| 16 |
Thakur M, Junho CVC, Bernhard SM, et al. NETs-induced thrombosis impacts on cardiovascular and chronic kidney disease [J/OL]. Circ Res, 2023, 132(8): 933-949.
|
| 17 |
Zhang ZH, Yang HX, Yang JL, et al. TLR3-mediated NET formation and macrophage activation in acute liver failure: targeting IL-36 signaling to attenuate inflammatory drivers [J/OL]. Int Immunopharmacol, 2025, 161: 115112.
|
| 18 |
Zhang H, Wang Y, Qu M, et al. Neutrophil, neutrophil extracellular traps and endothelial cell dysfunction in sepsis [J/OL]. Clin Transl Med, 2023, 13(1): e1170.
|
| 19 |
Woo YD, Jeong D, Chung DH. Development and functions of alveolar macrophages [J/OL]. Molecules and Cells, 2021, 44(5): 292-330.
|
| 20 |
Wang Y, Yang Q, Dong Y, et al. Piezo1-directed neutrophil extracellular traps regulate macrophage differentiation during influenza virus infection [J/OL]. Cell Death and Disease, 2025, 16(1): 60.
|
| 21 |
Pei X, Liu L, Wang J, et al. Exosomal secreted SCIMP regulates communication between macrophages and neutrophils in pneumonia [J/OL]. Nat Commun, 2024, 15(1): 691.
|
| 22 |
Jarczak D, Nierhaus A. Cytokine storm-definition, causes, and implications [J/OL]. Int J Mol Sci, 2022, 23(19): 11740.
|
| 23 |
Duan T, Du Y, Xing C, et al. Toll-like receptor signaling and its role in cell-mediated immunity [J/OL]. Front Immunol, 2022, 13: 812774.
|
| 24 |
Zhou C, Gao Y, Ding P, et al. The role of CXCL family members in different diseases[J/OL]. Cell Death Discov, 2023, 9(1): 212.
|
| 25 |
Chen Y, Wang J, Liu C, et al. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19 [J/OL]. Mol Med, 2020, 26(1): 97.
|
| 26 |
Wu T, Yang W, Sun A, et al. The role of CXC chemokines in cancer progression [J/OL]. Cancers, 2022, 15(1): 167.
|
| 27 |
Singh S, Anshita D, Ravichandiran V. MCP-1: Function, regulation, and involvement in disease [J/OL]. Int Immunopharmacol, 2021, 101: 107598.
|
| 28 |
Wang K, Wang M, Liao X, et al. Locally organised and activated Fth1hi neutrophils aggravate inflammation of acute lung injury in an IL-10-dependent manner[J/OL]. Nat Commun, 2022, 13(1): 7703.
|
| 29 |
Sun Z, Chen A, Fang H, et al. B cell-derived IL-10 promotes the resolution of lipopolysaccharide-induced acute lung injury [J/OL]. Cell Death Dis, 2023, 14(7): 418.
|
| 30 |
Schmit T, Guo K, Tripathi JK, et al. Interferon-γ promotes monocyte-mediated lung injury during influenza infection [J/OL]. Cell Rep, 2022, 38(9): 110456.
|
| 31 |
Verma AK, McKelvey M, Uddin MB, et al. IFN-γ transforms the transcriptomic landscape and triggers myeloid cell hyperresponsiveness to cause lethal lung injury [J/OL]. Front Immunol, 2022, 13: 1011132.
|
| 32 |
Sun Y, Hu B, Stanley G, et al. IFN-γ is protective in cytokine release syndrome-associated extrapulmonary acute lung injury [J/OL]. Am J Respir Cell Mol Biol, 68(1): 75-89.
|
| 33 |
Hudock KM, Collins MS, Imbrogno M, et al. Neutrophil extracellular traps activate IL-8 and IL-1 expression in human bronchial epithelia [J/OL]. Am J Physiol Lung Cell Mol Physiol, 2020, 319(1): L137-L147.
|
| 34 |
Liu X, Hussain R, Mehmood K, et al. Mitochondrial-Endoplasmic Reticulum Communication-Mediated Oxidative Stress and Autophagy[J/OL]. BioMed Research International, 2022, 2022: 6459585. DOI: 10.1155/2022/6459585.
|
| 35 |
Li J, Zhang J, Shi M, et al. Crosstalk between inflammation and hemorrhage/coagulation disorders in primary blast lung injury [J/OL]. Biomolecules, 2023, 13(2): 351.
|
| 36 |
Xue Q, Yan D, Chen X, et al. Copper-dependent autophagic degradation of GPX4 drives ferroptosis[J/OL]. Autophagy, 2023, 19(7): 1982-1996.
|
| 37 |
Chaudhary N, Jayaraman A, Reinhardt C, et al. A single-cell lung atlas of complement genes identifies the mesothelium and epithelium as prominent sources of extrahepatic complement proteins [J/OL]. Mucosal Immunol, 2022, 15(5): 927-939.
|
| 38 |
Detsika MG, Palamaris K, Dimopoulou I, et al. The complement cascade in lung injury and disease [J/OL]. Respir Res, 2024, 25(1): 20.
|
| 39 |
Pryzdial ELG, Leatherdale A, Conway EM. Coagulation and complement: key innate defense participants in a seamless web [J/OL]. Front in Immunol, 2022, 13: 918775.
|
| 40 |
Barrett CD, Maginot ER, Moore EE, et al. Hyperfibrinolysis is associated with complement activation following trauma [J/OL]. Thromb Haemost, 2025.
|
| 41 |
Murad D, Paracha RZ, Nisar M. Unravelling the impact of SARS-CoV-2 on hemostatic and complement systems: a systems immunology perspective [J/OL]. Front Immunol, 2025, 15: 1457324.
|
| 42 |
Ghanbari EP, Jakobs K, Puccini M, et al. The role of NETosis and complement activation in COVID-19-associated coagulopathies [J/OL]. Biomedicines, 2023, 11(5): 1371.
|
| 43 |
Kuzucuoğlu M, Balta C, Altun E, et al. Effects of different treatment modalities on lung injury in experimental pulmonary contusion model [J/OL]. J Surg Res, 2025, 307: 100-106.
|
| 44 |
Mokra D, Porvaznik I, Mokry J. N-acetylcysteine in the treatment of acute lung injury: perspectives and limitations[J/OL].Int J Mol Sci, 2025, 26(6): 2657.
|
| 45 |
Heydari S, Khoshmohabat H, Akerdi AT, et al. Evaluating the effect of montelukast tablets on respiratory complications in patients following blunt chest wall trauma: a double-blind, randomized clinical trial [J/OL]. Chin J Traumatol, 2023, 26(2): 116-120.
|
| 46 |
Bobrow B, Luber SD, Potnuru P, et al. Identification of HIF1A as a therapeutic target during SARS-CoV-2-associated lung injury [J/OL]. JCI Insight, 10(14): e191463.
|
| 47 |
Merkl T, Astapenko D, Štichhauer R, et al. Exogenous surfactant for lung contusion causing ARDS: a systematic review of clinical and experimental reports [J/OL]. Clin Respir J, 2024, 18(5): e13776.
|
| 48 |
Nagashima F, Inoue S, Ohta M. A patient with severe polytrauma with massive pulmonary contusion and hemorrhage successfully treated with multiple treatment modalities: a case report [J/OL]. J Med Case Rep, 2020, 14(1): 69.
|
| 49 |
Bachoumas K, Levrat A, Le Thuaut A, et al. Epidural analgesia in ICU chest trauma patients with fractured ribs: retrospective study of pain control and intubation requirements [J/OL]. Ann Intensive Care, 2020, 10(1): 116.
|
| 50 |
Wilson LM, Saldanha IJ, Robinson KA. Active cycle of breathing technique for cystic fibrosis [J/OL]. Cochrane Database Syst Rev, 2023, 2(2): CD007862.
|
| 51 |
Lagazzi E, Rafaqat W, Argandykov D, et al. Timing matters: early versus late rib fixation in patients with multiple rib fractures and pulmonary contusion [J/OL]. Surgery, 2024, 175(2): 529-535.
|
| 52 |
Li S, Qin Q, Luo D, et al. IL-17 is a potential biomarker for predicting the severity and outcomes of pulmonary contusion in trauma patients [J/OL]. Biomed Rep, 2021, 14(1): 5.
|
| 53 |
Dong H, Zhang Y, Zhou Y, et al. Gastrodia elata blume extract alleviates sepsis-induced lung injury by suppressing IL-23/IL-17 a axis [J/OL]. Fitoterapia, 2025, 184: 106624.
|
| 54 |
Oh JW, Lee TY, Chae M. The practicality of interleukin-6 in prognosis of blunt chest trauma in korea: a retrospective study [J/OL]. J Trauma Inj, 2023, 36(2): 114-120.
|
| 55 |
Fang J, Ding H, Huang J, et al. Mac-1 blockade impedes adhesion-dependent neutrophil extracellular trap formation and ameliorates lung injury in LPS-induced sepsis [J/OL]. Front Immunol, 2025, 16: 1548913.
|
| 56 |
Du Y, Chen Y, Li F, et al. Genetically engineered cellular nanovesicle as targeted DNase I delivery system for the clearance of neutrophil extracellular traps in acute lung injury [J/OL]. Adv Sci, 2023, 10(32): 2303053.
|
| 57 |
Cheng P, Li S, Chen H. Macrophages in lung injury, repair, and fibrosis [J/OL]. Cells, 2021, 10(2): 436.
|
| 58 |
Simón-Fuentes M, Ríos I, Herrero C, et al. MAFB shapes human monocyte–derived macrophage response to SARS-CoV-2 and controls severe COVID-19 biomarker expression [J/OL]. JCI Insight, 8(24): e172862.
|
| 59 |
Xia L, Zhang C, Lv N, et al. AdMSC-derived exosomes alleviate acute lung injury via transferring mitochondrial component to improve homeostasis of alveolar macrophages [J/OL]. Theranostics, 2022, 12(6): 2928-2947.
|
| 60 |
Wang L, Tang Y, Tang J, et al. Endothelial cell‐derived extracellular vesicles expressing surface VCAM1 promote sepsis‐related acute lung injury by targeting and reprogramming monocytes [J/OL]. J Extracell Vesicles, 2024, 13(3): e12423.
|
| 61 |
Huang W, Fu G, Wang Y, et al. Immunometabolic reprogramming of macrophages with inhalable CRISPR/Cas9 nanotherapeutics for acute lung injury intervention [J/OL]. Acta Biomater, 2024, 181: 308-316.
|
| 62 |
Zhang Y, Liang X, Bao X, et al. Toll-like receptor 4 (TLR4) inhibitors: current research and prospective [J/OL]. Eur J Med Chem, 2022, 235: 114291.
|
| 63 |
Hong H, Lou S, Zheng F, et al. Hydnocarpin D attenuates lipopolysaccharide-induced acute lung injury via MAPK/NF-κB and Keap1/Nrf2/HO-1 pathway [J/OL]. Phytomedicine, 2022, 101: 154143.
|
| 64 |
Zou G, Li L, Gao L, et al. Goniothalamin prevents lipopolysaccharide-induced acute lung injury and inflammation via TLR-4/NF-κB signaling pathway [J/OL]. J Biochem Mol Toxicol, 2023, 37(11): e23461.
|
| 65 |
Han DW, Oh JE, Lim BJ, et al. Dexmedetomidine attenuates subarachnoid hemorrhage-induced acute lung injury through regulating autophagy and TLR/NFκB signaling pathway [J/OL]. Korean J Anesthesiol, 2022, 75(6): 518-529.
|
| 66 |
Kadam AH, Schnitzer JE. Progression of acute lung injury in intratracheal LPS rat model: efficacy of fluticasone, dexamethasone, and pirfenidone [J/OL]. Pharmacology, 2024, 109(1): 22-33.
|
| 67 |
Song Y, Xu C, Wu J, et al. Palmatine alleviates LPS-induced acute lung injury via interfering the interaction of TAK1 and TAB1 [J/OL]. Biochem Pharmacol, 2022, 202: 115120.
|
| 68 |
Sanders M, Beringer P. Immunomodulatory activity of omadacycline in vitro and in a murine model of acute lung injury [J/OL]. mSphere, 9(11): e0067124.
|
| 69 |
Salama A, El-Fadaly AA, Elgohary R. Effect of atorvastatin on lipopolysaccharide-induced lung inflammation and hypoxia in mice; modulation of HIF-1α, CINC and MIP-2 [J/OL]. Immunopharmacol Immunotoxicol, 2024, 47(1): 85-93.
|
| 70 |
Emre AS, Mehtap S, Cem D, et al. Cannabidiol protects lung against inflammation and apoptosis in a rat model of blunt chest trauma via Bax/Bcl-2/Cas-9 signaling pathway [J/OL]. Eur J Trauma Emerg Surg, 2025, 51(1): 95.
|
| 71 |
Mesaki K, Juvet S, Yeung J, et al. Immunomodulation of the donor lung with CRISPR-mediated activation of IL-10 expression[J/OL]. J Heart Lung Transplant, 2023, 42(10): 1363-1377.
|
| 72 |
Wang F, Chen M, Ma J, et al. Integrating bulk and single-cell sequencing reveals the phenotype-associated cell subpopulations in sepsis-induced acute lung injury [J/OL]. Front Immunol, 2022, 13: 981784.
|
| 73 |
Liu C, Yin Z, Feng T, et al. An integrated network pharmacology and RNA-Seq approach for exploring the preventive effect of Lonicerae japonicae flos on LPS-induced acute lung injury [J/OL]. J Ethnopharmacol, 2021, 264: 113364.
|
| 74 |
Li Y, Cao Y, Xiao J, et al. Inhibitor of apoptosis-stimulating protein of p53 inhibits ferroptosis and alleviates intestinal ischemia/reperfusion-induced acute lung injury [J/OL]. Cell Death Differ, 2020, 27(9): 2635-2650.
|
| 75 |
Kong L, Deng J, Zhou X, et al. Sitagliptin activates the p62–Keap1–Nrf2 signalling pathway to alleviate oxidative stress and excessive autophagy in severe acute pancreatitis-related acute lung injury [J/OL]. Cell Death Dis, 2021, 12(10): 928.
|
| 76 |
Ruan Y, Fan Y, Xie Y, et al. Modified Xiaoqinglong decoction alleviates lipopolysaccharide-induced acute lung injury in mice by regulating arachidonic acid metabolism and exerting anti-apoptotic and anti-inflammatory effects [J/OL]. Anat Rec (Hoboken), 2022, 305(7): 1672-1681.
|
| 77 |
Luo XQ, Duan JX, Yang HH, et al. Epoxyeicosatrienoic acids inhibit the activation of NLRP3 inflammasome in murine macrophages [J/OL]. J Cell Physiol, 2020, 235(12): 9910-9921.
|
| 78 |
Zhang Y, Liu Y, Sun J, et al. Arachidonic acid metabolism in health and disease [J/OL]. MedComm, 2023, 4(5): e363.
|
| 79 |
Sendo F, Yoshitake H, Araki Y. Targeting of neutrophil activation in the early phase of the disease for prevention of coronavirus disease-19 severity [J/OL]. Microbiol Immunol, 2022, 66(6): 264-276.
|
| 80 |
Shi H, Zuo Y, Navaz S, et al. Endothelial cell-activating antibodies in COVID-19 [J/OL]. Arthritis & Rheumatology (hoboken, N.j.), 2022, 74(7): 1132-1138.
|
| 81 |
Carvelli J, Demaria O, Vély F, et al. Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis [J/OL]. Nature, 2020, 588(7836): 146-150.
|
| 82 |
Alsabani M, Abrams ST, Cheng Z, et al. Reduction of NETosis by targeting CXCR1/2 reduces thrombosis, lung injury, and mortality in experimental human and murine sepsis [J/OL]. Br J Anaesth, 2022, 128(2): 283-293.
|
| 83 |
Okeke EB, Louttit C, Fry C, et al. Inhibition of neutrophil elastase prevents neutrophil extracellular trap formation and rescues mice from endotoxic shock [J/OL]. Biomaterials, 2020, 238: 119836.
|
| 84 |
Liu FC, Yu HP, Liao CC, et al. Corilagin inhibits neutrophil extracellular trap formation and protects against hydrochloric acid/lipopolysaccharide-induced acute lung injury in mice by suppressing the STAT3 and NOX2 signaling pathways [J/OL]. Antioxidants, 2024, 13(4): 491.
|
| 85 |
Zhou S, Wang Z, Gao L, et al. C5a/C5aR1 axis as a key driver promotes epithelial-to-mesenchymal transition in airway epithelial cells in silica nanoparticles-induced pulmonary fibrosis [J/OL]. Int Immunopharmacol, 2023, 125(Pt B): 111112.
|
| 86 |
Mastaglio S, Ruggeri A, Risitano AM, et al. The first case of COVID-19 treated with the complement C3 inhibitor AMY-101 [J/OL]. Clin Immunol, 2020, 215: 108450.
|
| 87 |
Laurence J, Mulvey JJ, Seshadri M, et al. Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19 [J/OL]. Clin Immunol, 2020, 219: 108555.
|
| 88 |
Yu Y, Jiang P, Sun P, et al. Pulmonary coagulation and fibrinolysis abnormalities that favor fibrin deposition in the lungs of mouse antibody-mediated transfusion-related acute lung injury [J/OL]. Mol Med Rep, 2021, 24(2): 601.
|
| 89 |
Huang CY, Deng JS, Huang WC, et al. Attenuation of lipopolysaccharide-induced acute lung injury by hispolon in mice, through regulating the TLR4/PI3K/Akt/mTOR and Keap1/Nrf2/HO-1 pathways, and suppressing oxidative stress-mediated ER stress-induced apoptosis and autophagy 0 [J/OL]. Nutrients, 2020, 12(6): 1742.
|
| 90 |
Na E, Allen E, Baird LA, et al. Epithelial LIF signaling limits apoptosis and lung injury during bacterial pneumonia [J/OL]. Am J Physiol Lung Cell Mol Physiol, 2022, 322(4): L550-L563.
|